CD27 and Miyoshi myopathy: Univariate analysis showed that ISS stage III, CD27 + T cell ≥ 20%, BMPC proportion ≥ 31.49%, age ≥ 65 years, β2-MG ≥ 3.5 mg/L, affected the PFS of MM patients (P < 0.05).